Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
PREHOSPITAL AGITATION AND SEDATION TRIAL (PHAST)
The goal of the PHAST is to demine whether haloperidol is superior to midazolam for the sedation of agitated patients in the prehospital environment
The primary outcome is the time to a Richmond Agitation and Sedation Scale (RASS) ≤1
o The RASS is a well validated standardized score to measure a patient's agitation
The secondary outcomes are
Mercy EMS will be the only EMS agency in the Commonwealth of Pennsylvania carrying haloperidol
Identification of potential study patients will be per state protocols
Exclusion Criteria for the study
Age <18
Pregnant
Allergic to study medication
Transport to hospital other than Mercy Fitzgerald Hospital
Unable to reach medical command prior to giving medication
When a paramedic identifies a possible study candidate, the paramedic will consult medical command to see if the patient is appropriate for the study
If the medical command agrees the patient is appropriate for the study, patients will be randomized to
Odd days: Haloperidol 5mg IM (age <65) or haloperidol 2.5 mg IM (age ≥65)
Even days: Midazolam 0.05 mg IM to maximum of 5mg IM (age <65) or maximum of 2.5mg (age ≥65)
The RASS will be documented by the prehospital providers every 5 minutes until arrival at the hospital
Once the patient arrives at the ED, the RASS will be documented in PICIS® by the emergency department nurse at the time of triage and at a minimum of hourly until the RASS =0 or 1 for 2 consecutive hours
Questions may be directed to Dr. Isenberg at disenberg@mercyhealth.org or at (267) 205-6453
Richmond Agitation Sedation Scale
RASS RASS Description
4 Combative, violent, danger to staff
3 Pulls or removes tube(s) or catheters; aggressive
2 Frequent non-purposeful movement
1 Anxious, apprehensive, but not aggressive 0 Alert and calm
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Haloperidol | Experimental | IM Haloperidol |
|
| IM Midazolam | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Haloperidol | Drug | 5mg IM |
| |
| Midazolam |
| Measure | Description | Time Frame |
|---|---|---|
| Time to sedation | 10 minutes |
Not provided
Not provided
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Derek Isenberg, MD | Mercy Catholic Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mercy Catholic Medical Center | Darby | Pennsylvania | 19023 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011595 | Psychomotor Agitation |
| ID | Term |
|---|---|
| D020820 | Dyskinesias |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D011596 | Psychomotor Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D006220 | Haloperidol |
| D008874 | Midazolam |
| ID | Term |
|---|---|
| D002090 | Butyrophenones |
| D007659 | Ketones |
| D009930 | Organic Chemicals |
| D001569 | Benzodiazepines |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
IM midazolam |
|
| D019954 |
| Neurobehavioral Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D000096762 | Aberrant Motor Behavior in Dementia |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D001552 |
| Benzazepines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |